This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Invitrogen
other brands :
NeoMarkers, Lab Vision, Endogen, Pierce, BioSource International, Zymed Laboratories, Caltag, Molecular Probes, Research Genetics, Life Technologies, Applied Biosystems, GIBCO BRL, ABgene, Dynal, Affinity BioReagents, Nunc, Invitrogen, NatuTec, Oxoid, Richard-Allan Scientific, Arcturus, Perseptive Biosystems, Proxeon, eBioscience
product type :
antibody
product name :
BTBD6 Polyclonal Antibody
catalog :
PA5-99596
quantity :
100 uL
price :
US 464.00
clonality :
polyclonal
host :
domestic rabbit
conjugate :
nonconjugated
reactivity :
human, rat
application :
western blot, immunohistochemistry, immunohistochemistry - paraffin section
product information
Product Type :
Antibody
Product Name :
BTBD6 Polyclonal Antibody
Catalog # :
PA5-99596
Quantity :
100 uL
Price :
US 464.00
Clonality :
Polyclonal
Purity :
Affinity chromatography
Host :
Rabbit
Reactivity :
Human, Rat
Applications :
Immunohistochemistry (Paraffin): 1:50-1:200, Western Blot: 1:1,000
Species :
Human, Rat
Isotype :
IgG
Storage :
-20 C
Description :
Adapter protein for the CUL3 E3 ubiquitin-protein ligase complex. Involved in late neuronal development and muscle formation.
Immunogen :
A synthesized peptide derived from human BTBD6(Accession Q96KE9), corresponding to amino acid residues G296-Y346.
Format :
Liquid
Applications w/Dilutions :
Immunohistochemistry (Paraffin): 1:50-1:200, Western Blot: 1:1,000
Aliases :
BDPL; BTB (POZ) domain containing 6; BTB domain containing 6; BTB domain protein BDPL; BTB/POZ domain-containing protein 6; Btbd6; glucocorticoid receptor AF-1 coactivator-1; lens BTB domain protein; LOW QUALITY PROTEIN: BTB/POZ domain-containing protein 6
company information
Invitrogen
Thermo Fisher Scientific
81 Wyman Street
Waltham, MA USA 02451
https://www.thermofisher.com81 Wyman Street
Waltham, MA USA 02451
800-678-5599
headquarters: USA
questions and comments